Samantha Semenkow
Stock Analyst at Citigroup
(3.18)
# 1,045
Out of 5,241 analysts
80
Total ratings
44.78%
Success rate
3.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CPRX Catalyst Pharmaceuticals | Downgrades: Neutral | $35 → $32 | $31.18 | +1.03% | 5 | May 8, 2026 | |
| SYRE Spyre Therapeutics | Maintains: Buy | $64 → $97 | $74.92 | +29.47% | 2 | May 6, 2026 | |
| WVE Wave Life Sciences | Maintains: Buy | $30 → $24 | $6.77 | +254.51% | 3 | May 4, 2026 | |
| NKTR Nektar Therapeutics | Maintains: Buy | $123 → $151 | $70.62 | +113.82% | 3 | Apr 21, 2026 | |
| BHVN Biohaven | Maintains: Buy | $14 → $17 | $8.76 | +94.06% | 3 | Apr 2, 2026 | |
| BEAM Beam Therapeutics | Maintains: Buy | $64 → $68 | $27.93 | +143.47% | 4 | Mar 26, 2026 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $131 → $142 | $90.52 | +56.87% | 3 | Mar 20, 2026 | |
| BIOA BioAge Labs | Maintains: Buy | $15 → $52 | $17.66 | +194.45% | 6 | Mar 10, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $38 → $46 | $28.17 | +63.29% | 2 | Mar 5, 2026 | |
| LRMR Larimar Therapeutics | Maintains: Buy | $12 → $14 | $3.58 | +291.06% | 7 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $15.73 | +109.79% | 1 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $35 | $29.29 | +19.49% | 4 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,124 → $1,091 | $799.32 | +36.49% | 8 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $100 | $38.69 | +158.46% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4.25 | $2.93 | +45.05% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $5 | $17.55 | -71.51% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $3.31 | +202.11% | 4 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $2.00 | +100.00% | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.77 | +218.73% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $3.07 | +388.60% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $20.43 | +291.58% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $2.62 | +472.52% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $27.49 | +81.88% | 3 | Sep 27, 2023 |
Catalyst Pharmaceuticals
May 8, 2026
Downgrades: Neutral
Price Target: $35 → $32
Current: $31.18
Upside: +1.03%
Spyre Therapeutics
May 6, 2026
Maintains: Buy
Price Target: $64 → $97
Current: $74.92
Upside: +29.47%
Wave Life Sciences
May 4, 2026
Maintains: Buy
Price Target: $30 → $24
Current: $6.77
Upside: +254.51%
Nektar Therapeutics
Apr 21, 2026
Maintains: Buy
Price Target: $123 → $151
Current: $70.62
Upside: +113.82%
Biohaven
Apr 2, 2026
Maintains: Buy
Price Target: $14 → $17
Current: $8.76
Upside: +94.06%
Beam Therapeutics
Mar 26, 2026
Maintains: Buy
Price Target: $64 → $68
Current: $27.93
Upside: +143.47%
Rhythm Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $131 → $142
Current: $90.52
Upside: +56.87%
BioAge Labs
Mar 10, 2026
Maintains: Buy
Price Target: $15 → $52
Current: $17.66
Upside: +194.45%
Agios Pharmaceuticals
Mar 5, 2026
Maintains: Buy
Price Target: $38 → $46
Current: $28.17
Upside: +63.29%
Larimar Therapeutics
Feb 25, 2026
Maintains: Buy
Price Target: $12 → $14
Current: $3.58
Upside: +291.06%
Feb 17, 2026
Initiates: Buy
Price Target: $33
Current: $15.73
Upside: +109.79%
Feb 10, 2026
Maintains: Buy
Price Target: $26 → $35
Current: $29.29
Upside: +19.49%
Jan 8, 2026
Maintains: Buy
Price Target: $1,124 → $1,091
Current: $799.32
Upside: +36.49%
Dec 9, 2025
Maintains: Buy
Price Target: $60 → $100
Current: $38.69
Upside: +158.46%
Nov 11, 2025
Maintains: Neutral
Price Target: $5 → $4.25
Current: $2.93
Upside: +45.05%
Oct 29, 2025
Downgrades: Sell
Price Target: $5
Current: $17.55
Upside: -71.51%
Aug 14, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $3.31
Upside: +202.11%
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $2.00
Upside: +100.00%
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $3.77
Upside: +218.73%
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $3.07
Upside: +388.60%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $20.43
Upside: +291.58%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.62
Upside: +472.52%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $27.49
Upside: +81.88%